Billy Pan, MD
Glaucoma Specialist · Beverly Hills, CANPI 1760828248
Payments from drug & device makers
Across 760 payments — averaging $330.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$55K
- Bausch & Lomb Americas Inc.$53K
- Glaukos Corporation$44K
- Aerie Pharmaceuticals, Inc.$28K
- Nova Eye, Inc.$25K
- Alcon$19K
- plus $27K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 238 | $54,927 |
| Bausch & Lomb Americas Inc. | 105 | $52,847 |
| Glaukos Corporation | 44 | $44,225 |
| Aerie Pharmaceuticals, Inc. | 61 | $28,310 |
| Nova Eye, Inc. | 7 | $24,686 |
| Alcon | 92 | $18,694 |
| Sight Sciences, Inc. | 24 | $8,827 |
| NEW World Medical,inc. | 35 | $5,690 |
| Alcon Research LLC | 4 | $5,479 |
| Ivantis, Inc | 6 | $2,658 |
| Johnson & Johnson Surgical Vision, Inc. | 11 | $570 |
| Tarsus Pharmaceuticals, Inc. | 15 | $532 |
| Thea Pharma Inc. | 22 | $483 |
| Sun Pharmaceutical Industries Inc. | 13 | $407 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 10 | $376 |
| Novartis | 19 | $336 |
| Carl Zeiss Meditec USA, Inc. | 3 | $261 |
| Oyster Point Pharma, Inc. | 8 | $256 |
| Carl Zeiss Meditec, Inc. | 1 | $210 |
| Lumibird Medical Inc. | 1 | $192 |
| Rxsight Inc | 4 | $148 |
| Ocular Therapeutix, Inc. | 7 | $127 |
| Akorn Operating Company LLC | 7 | $118 |
| Amgen(2 entities) | 5 | $101 |
| Kala Pharmaceuticals, Inc. | 4 | $79 |
| Mallinckrodt Hospital Products Inc. | 3 | $64 |
| Eyevance Pharmaceuticals LLC | 3 | $62 |
| Omeros Corporation | 3 | $47 |
| Biotissue Holdings Inc. | 2 | $42 |
| Dompe US, Inc. | 1 | $24 |
| Akorn, Inc. | 1 | $21 |
| Harrow Eye, LLC | 1 | $19 |
How this compares
$250,816 in reported general payments places this provider in the 90th percentile of 64 glaucoma specialist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other glaucoma specialist in Beverly Hills
- Jason BacharachPetaluma$2.4M
- Jacob BrubakerSacramento$849K
- Andrew CampSan Diego$511K
- Robert ChangStanford$490K
- Daniel KrivoyCulver City$171K
- Felise May BarteSanta Clara$121K
- Houman VosoghiWestlake Village$119K
- Jeffrey GoldbergStanford$105K
- Anurag ShrivastavaPalo Alto$102K
- Sophia WangStanford$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.